Home | Articles
Published on:September 2021
Indian Journal of Pharmaceutical Education and Research, 2021; 55(3s):xx-xx
Original Article | doi:10.5530/ijper.55.3s.x

Simultaneous Estimation of Pregabalin and Etoricoxib using Novel HPLC Method: An Application in Quantitative Analysis of Pharmaceutical Dosage Forms


Authors and affiliation (s):

Amit Chaudhary, Bhuvnesh Kumar Singh*

1School of Pharmacy, Abhilashi University, Mandi, Himachal Pradesh, INDIA.

2Department of Pharmaceutical Analysis, School of Pharmacy, Abhilashi University, Mandi, Himachal Pradesh, INDIA.

Abstract:

Introduction: A new optimised method was developed for simultaneous estimation of new FDA approved drugs using RP-HPLC method that would emphasize the use of these drugs in various industries for quality measurements. Objectives: The objective of the present study to develop and validate a new simple, novel, precise, rapid, reliable, accurate and reproducible reverse-phase high-performance liquid chromatography (RPHPLC) technique for simultaneous estimation of Pregabalin (PREG) and Etoricoxib (ETOR) in bulk and formulation. Material and Mehtods: This separation was done by using a mixture of methanol: acetonitrile: phosphate buffer (pH 5) at the ratio of (40:20:20) as mobile phase, with a hypersil ODS, C18 (250 mm × 4.6 mm, i.d.2.5 μm). The flow rate was 1.0 ml min-1 and effluents were monitored at 215 nm by using UV-visible detector with injection volume was 20 μl. Results: They were found to be linear over a range of 12.5–37.5 μg ml-1 and 150–450 μg ml-1 for PREG and ETOR respectively. The retention time of PREG and ETOR was 3.523 min and 4.702 min, respectively. The mean percentage recoveries of PREG and ETOR were found to be 100.27% and 99.91%, respectively. The LOD was found 1.89 and 2.26 μg ml-1 and the LOQ were found 5.73 and 6.84 μg ml-1, for PREG and ETOR, respectively. Conclusion: This novel validated economical methods could be applicable for analysis of PREG and ETOR in pharmaceutical industries.

Key words: Pregabalin, Etoricoxib, Method Validation, Simultaneous, ICH.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs